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Prognostic Implication of the Lymphangitic Carcinomatosis Pattern
on Perfusion Lung Scan
Mathieu Charest, MD*, Shadia Armanious, MD
Diagnostic Imaging Department, Lakeshore General Hospital, Montreal, Quebec, CanadaAbstractPurpose: Findings not associated with thromboembolic disease on routine perfusion lung scan may sometimes have particular clinical
significance. We wanted to assess the clinical importance and overall survival after the recognition of a lymphangitic carcinomatosis pattern
on perfusion lung scan.
Case report:We report a case of lymphangitic carcinomatosis pattern on perfusion lung scan performed in a previously healthy patient who
had rapid progressive course and died the next day.
Method: A Medline search of case reports that describes either lymphangitic carcinomatosis or tumour microemboli on perfusion lung scan.
Results: There were a total of 32 patients identified in 21 articles from various countries, including our case. The studied perfusion pattern
was reported more often in female patients (81%) was associated with a progressive history of dyspnea (69%) and normal or mild findings on
chest radiograph (58%). Of the 29 patients with available outcome data, 79% (23/29) had a progressive course after the lung scan inter-
pretation. In 18 of these 23 cases, the actual interval of survival was given: 67% of these patients (12/18) died within the first month.
Discussion: A lymphangitic carcinomatosis perfusion pattern on scintigraphic imaging is associated with a poor prognosis. Nuclear medicine
physicians should be aware of this association and that raising the suspicion for a metastatic process may make a difference in the treatment
plan of these patients.ResumeObjectif : Les constatations qui ne decoulent pas d’une maladie thromboembolique revelee par scintigraphie pulmonaire de perfusion de
routine peuvent parfois e^tre d’une signification clinique particuliere. Le but etait d’evaluer l’importance clinique et le taux de survie general
suivant le diagnostic d’une forme de carcinomatose lymphangitique decelee par scintigraphie pulmonaire de perfusion.
Rapport de cas : Patient en sante chez qui une scintigraphie pulmonaire de perfusion revele une forme de carcinomatose lymphangitique qui
conna^ıt une evolution rapide et duquel le patient decede le jour suivant.
Methode : Une recherche dans Medline de rapports de cas qui decrivent un carcinomatose lymphangitique ou une tumeur microembolique
revele par scintigraphie pulmonaire de perfusion.
Resultats : La recherche a permis de relever un total de 32 patients dans 21 articles provenant de differents pays, y compris le present cas. La
forme de perfusion a l’etude a ete relevee le plus souvent chez les femmes (81 %). Elle etait liee a des antecedents evolutifs de dyspnee
(69 %) et a produit des resultats normaux ou peu graves sur la radiographie pulmonaire (58 %). Des 29 patients dont les resultats etaient
accessibles, 79 % (23 sur 29) ont connu une evolution progressive de la maladie a la suite de l’interpretation de la scintigraphie pulmonaire.
Dans 18 des 23 cas, l’intervalle de survie reel etait donne : 67 % de ces patients (12 sur 18) sont decedes au cours du mois suivant.
Discussion : Une forme de carcinomatose lymphangitique decelee par scintigraphie pulmonaire est associee a un pronostic sombre. Les
medecins specialistes en medecine nucleaire doivent e^tre conscients de cette relation et du fait que de soulever un doute quant a un potentiel
metastatique peut avoir une incidence sur le plan de traitement de ces patients.
 2012 Canadian Association of Radiologists. All rights reserved.
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Figure 1. Planar ventilation and perfusion lung scintigraphy, demonstrating normal and homogeneous ventilation, but multiple peripheral subsegmental and
nonsegmental perfusion defects bilaterally are consistent with a lymphangitic carcinomatosis pattern. ANT ¼ anterior; LAO ¼ left anterior oblique; LPO ¼ left
posterior oblique; Lt Lat ¼ left lateral; perf ¼ perfusion; POST ¼ posterior; RAO ¼ right anterior oblique; RPO ¼ right posterior oblique; Rt Lat ¼ right
lateral; vent ¼ ventilation.
295Lymphangitic carcinomatosis on V/Q scan / Canadian Association of Radiologists Journal 63 (2012) 294e303Perfusion lung scan interpretation is certainly an impor-
tant part of the daily clinical work of most nuclear medicine
departments. Findings not associated with acute thrombo-
embolic disease, although infrequent and mostly benign in
nature, should be recognized because they may have
particular clinical significance as exemplified in this case
report. We recently encountered a case of a lymphangitic
carcinomatosis pattern on a perfusion lung scan. This
particular imaging pattern is well known to nuclear medicine
physicians, although the full clinical consequence of such
interpretation may be less well understood. We present the
case of a previously healthy patient who experienced rapid
deterioration of her condition and died the day after the
perfusion lung scan. This unfortunate chain of events trig-
gered a review of the medical literature to ascertain the role
of nuclear medicine when assessing the so-called lym-
phangitic carcinomatosis perfusion pattern. Prognostic
inference from the analysis performed by the authors shouldgive the reader a sense of the urgency to promptly report
these cases to the referring physician.
Case Report
A 34-year-old female patient presented to the emergency
department with exacerbation of a progressive history of
dyspnea, fatigue, and night sweats. There was no relevant
medical history and no significant thromboembolic risk
factors, and she was a lifetime nonsmoker. Because she had
already sought medical attention on 3 occasions with no
relief of her symptoms, the emergency physician ordered
a ventilation/perfusion (V/Q) lung scan to exclude an atypical
pulmonary embolism presentation.
The ventilation images showed homogeneous distribution
of the aerosols to both lungs, with no significant proximal
airway visualisation to suggest significant turbulent airways
disease such as bronchospasm or chronic obstructive
Table 1
Review of 32 cases from 21 articles that describe perfusion lung scan in keeping with either tumour microthrombi or lymphangitic carcinomatosis patt , and the survival interval after the perfusion scan
interpretation
Study no. Study Age (y)/sex Primary malignancy Symptoms CXR and CT Ventilation Perfusion Survival interval Histology
1 Pendergrass et al,19
1972 (case report)
42/M Poorly differentiated
metastatic gastric
adenocarcinoma,
treated by
chemotherapy
and radiotherapy
Increasing dyspnea,
weakness, and chest
pain 1 mo after the
initial diagnosis
CXR: fine
reticulo-endothelial
pattern
Not specified Fissure sign and
peripheral defec
The patient died
of sudden cardiac
arrest 3 d after
admission
Autopsy: massive,
diffuse, involvement
by metastatic
tumour of
peribronchial,
perivascular, septal,
and subpleural
lymphatics;
occlusion of
virtually all small
arteries and
arterioles by plugs
of tumour cells
and fibrin
2 Sadoff et al,20 1975
(case reports)
54/F Inflammatory
inoperable breast
carcinoma, treated
by local
radiotherapy
Dyspnea progressing
over 1 mo
CXR: normal Not specified Multiple defects,
irregular segmen
in RUL, LUL, R L
Responded to
chemotherapy,
normalized V/Q
scan 3 mo after
admission
No histology: lung
biopsy was
considered too
risky and
chemotherapy was
started based on
the presumptive
diagnosis of
lymphangitic
carcinomatosis
64/F Intraductal carcinoma
of the breast,
metastases to the
bone, on palliative
radiotherapy
Cough and dyspnea CXR: clear lung Not specified Multiple defects,
irregular segmen
in RUL, LUL, R L
Responded to
chemotherapy,
survival more
than 1 y
No histology: treated
by multiple drug
chemotherapy, based
on clinical findings
and after failure
of warfarin therapy
to improve the
shortness of breath
68/F Intraductal carcinoma
of the breast, bone
metastases on
palliative
radiotherapy
Pleuritic chest pain
and marked dyspnea
CXR: small left
pleural effusion
with clear lung
Not specified Multiple defects in
upper lung field
Responded to
chemotherapy and
showed marked
improvement in
2 wk and survived
more than 1 y
No histology: treated
by multiple drug
chemotherapy, based
on clinical findings
3 Green et al,1 1976
(case reports)
31/F Stage I breast
carcinoma (18 mo)
Dyspnea of 1-wk
duration
CXR: enlargement
of pulmonary
arteries
Normal Extensive peripher
defects
Died after a
progressive course,
2-3 mo (72 d) after
admission
Autopsy: Extensive
tumour deposits in
small arteries and
lymphatics
73/F Stage II breast
carcinoma (9 mo)
Dyspnea and cyanosis
of 1-mo duration
CXR: normal Not specified Numerous defects Died the day
of admission
Autopsy: extensive
tumour deposits in
many small arteries
and lymphatics
2
9
6
M
.
C
h
a
rest,
S
.
A
rm
a
n
iou
s
/
C
a
n
a
d
ia
n
A
sso
cia
tion
o
f
R
a
d
io
lo
g
ists
Jo
u
rn
a
l
6
3
(2
0
1
2
)
2
9
4e
3
0
3ern
ts
ts
M
ts
M
s
al
46/F Stage II breast
carcinoma (5 mo)
Follow-up CXR CXR: diffuse
interstitial and
nodular infiltrates
Normal Multiple defects Died 3 mo (71 d)
after transient
subjective
improvement after
radiotherapy
to the lungs
Autopsy: numerous
small foci of
lymphangitic
spread; no
tumour emboli
were observed
76/F Stage II breast
carcinoma (4 y)
Dyspnea and cough CXR: numerous
nodules
Normal Multiple defects Died 2 mo (40 d)
after admission
despite
chemotherapy
Autopsy: Many arteries
that contain nests
of tumour cells
within organized
thrombi and
extensive
lymphangitic spread
Sostman et al,2 1981
(case reports)
51/F Breast
adenocarcinoma,
diagnosed 2.5 y
earlier, treated
with chemotherapy
Progressively
worsening dyspnea
in the previous
few months
CXR: RV overload,
small pericardial
effusion and sign
of pulmonary
hypertension
Normal Numerous
subsegmental
perfusion defects
Died a few weeks
after admission
Autopsy: tumour
deposits in
pulmonary vessels
and interstitium
69/F Intraductal and
infiltrating breast
comedocarcinoma,
diagnosed 22 mo
earlier
Rapidly worsening
dyspnea at the end
of chemotherapy
CXR: normal Not specified Multiple defects
in keeping with
carcinomatosis
Survived after
follow-up at 4 mo
Open lung biopsy:
multiple arterial and
venous tumour
thrombi with areas
of distal
microinfarction
and occasional
lymphatic tumour
deposits
Boudreau et al,5 1982
(case report)
52/F Adenocarcinoma of
unknown primary
(no previous
oncologic history)
6 wk history of
pleuritic right-sided
chest pain and
fatigue
CXR: blunting of
costophrenic angles,
hyperinflation,
and mild increased
markings
Normal Multiple small
peripheral
subsegmental
defects
No response to initial
heparin therapy,
started on
chemotherapy after
the biopsy and
progress as an
outpatient
Open lung biopsy:
extensive embolic
adenocarcinoma
with an area of
peripheral infarction
Bates and Tranum,3
1982 (case reports)
47/F Infiltrating duct
carcinoma
metastatic to the
axilla, diagnosed
6 mo earlier, treated
with chemo- and
radiotherapy
Cough, hemoptysis,
dyspnea, and
pleuritic chest pain
CXR: slight
accentuation of
bronchovascular
markings on the
right
Normal Multiple segmental
and subsegmental
defects
Died 7 wk after the i
nitial symptoms,
despite
chemotherapy
Open lung biopsy:
metastatic breast
carcinoma tumour
seen in the
lymphatic and
pulmonary arterioles
42/F Duct carcinoma
diagnosed 7 mo
earlier
Nonproductive cough
of 1-mo duration
CXR: normal Matching the
perfusion
Scattered
subsegmental
defects in both lungs
Died of progressive
disease despite
chemotherapy
(interval not
specified)
Transbronchial biopsy:
metastatic
carcinoma, but the
location of tumour
cells could not be
specified
Crane et al,10 1984
(case reports)
44/F Metastatic ductal
carcinoma of the
breast (diagnosed
4 y earlier)
Dyspnea on exertion
without cough or chest
pain for 7 wk
CXR: slight
prominence of
central pulmonary
vasculature
Normal Multiple subsegmental
peripheral defects
Had cardiac arrest
4 d after admission
Autopsy: Tumour
emboli in 80% of the
muscular pulmonary
arteries; no pulmonary
lymphangitic
involvement
(continued on next page)
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Table 1 (continued )
Study no. Study Age (y)/sex Primary malignancy Symptoms CXR and CT Ventilation Perfusion Survival interval Histology
49/F Intraductal carcinoma
of the left breast
(diagnosed 5 y
earlier)
Weakness and dyspnea
rapidly increasing
over 3 d; in
respiratory distress
on admission
CXR: elevation of right
hemidiaphragm and
minimal atelectasis
at right base
Not specified Multiple small
peripheral
subsegmental
defects
Cardiac arrest
during right heart
catheterization,
performed after the
perfusion scan
(interval not
specified)
Autopsy: extensive
pulmonary arterial
obstruction in
vessels of all sizes
with unorganized
masses of tumour
cells; <5% of
lymphangitic
involvement
40/F Infiltrating ductal
carcinoma
(diagnosed 1 y
earlier)
3-wk history of
dyspnea at rest
CXR: enlarged
right hilum
Normal Multiple bilateral
peripheral defects
Received
chemotherapy for
1 mo based on
clinical findings,
was readmitted
6 wk later and died
shortly thereafter
(10 wk of onset)
Bronchoscopy: aborted
without biopsy; no
autopsy performed
8 Davis et al,11 1988
(interesting images)
58/F Known metastatic
breast cancer
Patient with
increasing dyspnea
CXR: fine reticular
pattern; CT chest:
few subpleural
nodules
Normal Multiple, bilateral
wedge-shaped
0defects (contour
mapping)
Follow-up not
specified
Open lung biopsy:
extensive
hematogenous
tumour deposits
9 Rawlinson et al,12
1988 (case report)
59/F No previous oncologic
history, pancreatic
carcinoma found at
autopsy
5-mo history of
progressive
exertional dyspnea
and intermittent
pleuritic chest pain
CXR: normal Normal Multiple small
peripheral defects
bilaterally
Deteriorated despite
anticoagulant
therapy and died
3 mo after
presentation
Autopsy:
carcinomatous
emboli in the
smaller branches of
the pulmonary
arteries
10 Chen et al,13 1991
(case report)
76/M Metastatic squamous
cell carcinoma of the
right lower lobe
bronchus; metastasis
to the RV and
pulmonary vessels
Dyspnea, appeared
in respiratory
distress on
admission
CT chest: pericardial
effusion, mediastinal
lymphadenopathy,
and a mass in the RV
with vascular
invasion of the main
trunk of the
pulmonary artery
Normal Multiple small
subsegmental
peripheral defects
Slight resolution
of the perfusion
abnormalities 1 mo
after radiotherapy
to the lung;
discharged in stable
condition thereafter
Open chest surgery:
performed to remove
the RV tumour;
multiple tumour
thrombi in the
pulmonary arteries
and veins were also
noted
11 Negrin et al,14 1995
(interesting image)
81/M Known prostate cancer Dyspnea CXR: faint interstitial
infiltrates
Matched and
mismatched defects
Contour mapping
configuration: small
linear perfusion
defects that outline
bronchopulmonary
segments
Follow-up not specified Pulmonary capillary
blood sampling
during angiogram:
numerous
adenocarcinoma
cells embolic casts
of microvessels
12 Van de Ven PJ et al,15
1997 (case report in
Dutch)
54/F Metastatic carcinoma
of the breast;
receiving megestrol
Respiratory distress of
a few weeks
CXR: RUL
postradiotherapy
fibrosis; chest CT:
diffuse subpleural
ground-glass
changes
Normal Segmental contour
pattern, interpreted
as nonehigh
probability of
pulmonary
embolism
Deteriorated despite
anticoagulant
therapy; incomplete
bronchoscopy
secondary to sinusal
tachycardia.; the
patient died shortly
after a rapid
deterioration of her
respiratory status,
3 wk after admission
Autopsy: multiple
thromboemboli with
tumour cells in both
small and large
vessels;
lymphangitic
carcinomatosis in
RUL with fibrous
pleuritis
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46/F Metastatic carcinoma
of the breast,
diagnosed 12 y
earlier; receiving
megestrol at the time
of admission
Atypical thrombotic
thrombocytopenic
purpura-like
syndrome
Not specified Not specified Segmental contour
pattern
Rapid deterioration 9 d
after admission with
right hemiparesis,
followed by
respiratory
insufficiency and
hypotension; the
patient was
intubated and
transferred to the
intensive care unit,
where she died of
arrhythmia
Autopsy: transmural
myocardial infarct
and lymphangitic
carcinomatosis
13 Vattimo et al,4 1998
(case reports)
49/F Breast
adenocarcinoma,
diagnosed 1 y earlier
Progressive dyspnea
of 8 d duration
CXR: normal Not specified Numerous small
defects in both
lungs, a fragmented
pattern
Progressively
deteriorated and
died of respiratory
failure 4 d after
admission
Autopsy: Neoplastic
cells within the
perivascular and
peribronchial
lymphatics
40/F Infiltrative ductal
breast carcinoma,
diagnosed 1.5 y
earlier
Progressive dyspnea,
nonproductive
cough of 2-wk
duration
CXR: moderate diffuse
interstitial and
alveolar opacities in
the left lung; CT
chest: linear
densities in the
upper lobes that
indicate thickened
interlobar septa
Not specified Fragmented pattern Dyspnea worsened,
and the patient died
of respiratory failure
12 d after
scintigraphy
Transbronchial biopsy:
diagnosis of
pulmonary
lymphangitic
carcinomatosis
14 Bennink et al,16 1998
(case report in
English)
57/M Treated for 6 mo for
combined NHL and
undifferentiated
carcinoma of
unknown origin;
ductal carcinoma of
the pancreas found
at autopsy
Subacute dyspnea at
rest and moderate
abdominal pain for
2 wk
CXR: bilateral
perihilar cuffing,
increased markings
of the lower
segments, and
increased density
of the left medial
segments
Almost normal Multiple small
subsegmental
peripheral defects
Died of a total AV
block despite
maximal supportive
therapy (interval not
specified)
Explorative
laparotomy:
combination of
NHL and diffuse
metastases of an
adenocarcinoma of
unknown origin;
autopsy: multiple
recent and semi-
organized tumour
emboli of pancreatic
origin in both lungs;
mild lymphangitic
carcinomatosis
15 Shadan et al,5 1999
(case report)
46/F Poorly differentiated
ovarian
adenocarcinoma
Clinical signs
suggestive of
pulmonary
embolism
CXR: normal; CT
chest: extensive
mediastinal
lymphadenopathy,
no thrombus
Normal Multiple branching
segmental defects
Patient developed
dyspnea and
cyanosis 48 h after
admission, and died
shortly after
unsuccessful
resuscitation
Autopsy:
thromboemboli
within small arteries
and arterioles of the
lungs
(continued on next page)
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Table 1 (continued )
Study no. Study Age (y)/sex Primary malignancy Symptoms CXR and CT Ventilation Perfusion Survival interval Histology
16 Walgraeve et al,6 2001
(interesting images)
30/M Gastric signet-ring-cell
adenocarcinoma
Progressive dyspnea,
hypoxemia and
thoracic pain for
3 wk
CXR and CT: results in
a working diagnosis
of asthma or
hyperventilation
Not specified Multiple small defects
in both lungs
The patient died
on the day the
chemotherapy was
started (interval not
specified)
Transbronchial lung
biopsy: tumour
thrombi in small
bronchial arterioles
and ectasic lymphatics
filled by tumour cells
17 Matsuba et al,17 2002
(case report in
Japanese, abstract in
English)
47/M Advanced metastatic
gastric cancer
Progressive dyspnea
and cough
CXR: revealed the
signs of cor
pulmonale
Not specified Multiple peripheral
perfusion defects
The patient died on the
third hospital day
Autopsy: Small
arteries and
arterioles occluded
by casts of tumour
cells in more than 60%
18 Mizumoto et al,18 2005
(case report in
Japanese, abstract in
English)
55/M Poorly differentiated
adenocarcinoma of
the stomach
2-wk history of
dyspnea and
general fatigue
CT chest: normal Not specified Multiple subsegmental
peripheral defects
Died of cardiac arrest
10 d after admission
Autopsy: pulmonary
arterial obstruction
with tumour cells
19 Stein et al,7 2005
(interesting images)
43/F Metastatic breast
cancer
Shortness of breath CXR: prominent
interstitial markings;
Chest CT: multiple
nodules with
thickening of the
bronchovascular
interstitium
Matching ventilation Multiple band-like
nonsegmental
defects, mostly to
the right lower
lung field
Survival not specified No histology
20 Iwamoto et al,8 2009
(case report in
Japanese)
70/F Known breast cancer
on hormonal therapy
Progressive shortness
of breath for 1 mo
CXR and CT: mild
interstitial changes,
with thickening of
the peripheral
interlobular septa
in HRCT
Not specified Small subsegmental
perfusion defects
in both lungs
Died 4 d after the
lung perfusion scan
(additional
information from the
researchers)
Transbronchial lung
biopsy: tumour
emboli in small
pulmonary arteries
21 Charest and
Armanious (our
case report)
34/F No known oncologic
history; extensive
high-grade
lymphoma found
at autopsy
Exacerbation of
progressive dyspnea,
fatigue, and night
sweats
CXR: normal; CT
chest: normal
Normal Multiple small
peripheral defects to
both upper and
lower lung zones
Died within 24 h
of admission despite
maximal supportive
therapy
Autopsy: high-grade
lymphoma and
multiple microthrombi
to small pulmonary
vessels
AV ¼ atrioventricular; CT ¼ computed tomography; CXR ¼ chest x-ray; HRCT ¼ high resolution CT; LUL ¼ left upper lobe; NHL ¼ non-Hodgkin lymphoma; RML ¼ right middle lobe; RUL ¼ right upper
lobe; RV ¼ right ventricle; V/Q ¼ ventilation/perfusion scan.
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301Lymphangitic carcinomatosis on V/Q scan / Canadian Association of Radiologists Journal 63 (2012) 294e303pulmonary disease. The perfusion images (Figure 1)
demonstrated multiple small peripheral perfusion defects to
both lungs and involved evenly both the upper and lower
lung zones. The impression of the lung scan report states that
this pattern of perfusion deficits was suspicious for lym-
phangitic carcinomatosis. The treating physician was directly
called and a computed tomography (CT) of the chest was
recommended.
Within the next hour, the patient underwent a sequential
CT of the head and neck, chest, abdomen, and pelvis,
because small palpable lymph nodes were found in the left
cervical area on physical examination and based on
a working diagnosis of possible diffuse lymphoma. The CT
angiography of the chest revealed no pulmonary embolism,
no significant lung parenchyma abnormalities, no pleural
effusions, and no mediastinal lymphadenopathy. The CT of
the neck showed few small lymph nodes along the anterior
and posterior left cervical space and in the left supra-
clavicular region. There also were very few nodes seen
along the posterior right cervical space. The CT of the
abdomen and pelvis demonstrated prominent retroperito-
neal lymphadenopathies along the periaortic, inter-
aortocaval, and celiac axis, and in the porta hepatis
regions.
At that point, the patient was hospitalized. The following
night, the respiratory status of the patient continued to
deteriorate rapidly. Although she was transferred to the
intensive care unit with maximal medical therapy and
ventilation support, she died the next morning before
chemotherapy could be initiated. The final pathology report
of the autopsy confirmed the diagnosis of high-grade
lymphoma with multiple and extensive pulmonary tumour
microemboli to both lungs.
Methods
To assess the prognostic implication of this imaging inter-
pretation, a systematic review of the medical literature was
performed. AMedline search of ‘‘lymphangitic carcinomatosis
and perfusion lung scan’’ returned only 8 studies [1e8].
A search for ‘‘tumor embolism and perfusion lung scan’’
returned 40 articles. From the available abstracts, only those
studies that describe diffuse subsegmental or multiple periph-
eral perfusion defects were included, which yielded 10 new
articles [9e18]. Twoadditional case reportswere included after
reading of the references of the other articles [19,20].
Thus, we have included, from the available literature, 20
articles from various countries: 16 in English, 1 in Dutch,
and 3 in Japanese. The 4 non-English articles were analysed
based on their very complete English abstract in 2 cases,
from the gracious participation of their researchers contacted
by e-mail for 1 article and from the translation of the original
article in the last one. All articles but 3 were full case reports
with variable information on the clinical presentation and
outcome of the described patients. Three articles were pub-
lished as ‘‘Interesting Images,’’ with only a brief description
of the imaging findings and pathology when available.The following data were collected for each patient re-
ported: age, sex, oncologic history, initial clinical presenta-
tion, available chest radiograph or chest CT results,
a description of the V/Q lung scan, clinical outcome, and
definite histologic information from either lung tissue sample
or autopsy report with respect to the lung parenchyma
process.Results
The review of these articles is striking in that the ‘‘frag-
mented perfusion’’ or ‘‘lymphangitic carcinomatosis’’
pattern was mainly reported in women and that the survival
was extremely poor (Table 1). A total of 32 patients were
identified from the literature, including our case. The
majority, 81%, were female patients (26/32), and the age at
the time of presentation ranged from 30-81 years old
(average, 53  13 years old).
Three patients did not have significant oncologic history but
were found at autopsy to have had pancreatic carcinoma (1
case), adenocarcinoma of unknown primary (1 case), and
diffuse high-grade lymphoma (1 case). One patient was
diagnosed with metastatic squamous cell carcinoma of the
right lower lobe bronchus with right ventricle and pulmonary
metastases at the time of presentation. The remaining 28
patients (90% [28/32]) had known cancer at the time of
presentation: breast carcinomas (21 cases), gastric carcinomas
(4 cases), ovarian adenocarcinoma (1 case), prostate carci-
noma (1 case), and non-Hodgkin lymphoma (1 case). Thus, the
majority of these patients had tumour from an epithelial origin
(94% [30/32]) as opposed to tumour of hematogenous origin in
6% (2/32), and none of sarcomatous origin.
Most patients (69% [22/32]) had a history of progressive
dyspnea over a few weeks. The other patients had a rapid
onset of dyspnea (4/32); a clinical presentation only
described as dyspnea or shortness of breath, with no infor-
mation on the progression of those symptoms (4/32); dete-
rioration of the radiologic images (1/32); or atypical
thrombotic thrombocytopenic purpura-like syndrome (1/32).
Except for 1 case report, all the other cases mentioned results
of initial radiologic evaluation. In 58% of these (18/31), the
initial chest radiograph or CT chest was reported as being
normal or near normal.
With regard to the outcome and the survival time after
recognition of the scintigraphic pattern on the perfusion lung
scan, the reported periods are as follows (Figure 2). In 3
patients, the outcomes were not communicated. Six patients
survived more than a month based on the follow-up infor-
mation available: one progressed as an outpatient (the
interval of follow-up was not specified), 1 patient survived at
least 1 month, 1 patient survived 3 months, 1 patient survived
4 months, and 2 patients survived 1 year. The cause of the
eventual deaths of these 6 cases was not communicated, but
their contribution to the survival assessment after the
perfusion lung scan was considered in the survival curve
analysis.
Figure 3. Kaplan-Meier survival curve of 23 patients with either available
follow-up or reported survival interval, after the initial perfusion lung scan,
describing the lymphangitic carcinomatosis pattern. The ‘‘’’ represents the
patients lost to follow-up who contribute to the overall survival curve (also
known as the censored data).
32 patients included 
3 without follow-up data
29 with follow-up data
6 survived at least 1 month
23 reported deaths
5 without interval data 
18 died at < 3 months  
12 died at < 1 month
6 died at > 1 month
1 follow-up of unknown duration 
2 follow-up of < 3 months 
3 follow-up of > 3 months 
Figure 2. Patient survival interval data diagram. In grey, the cases with available follow-up or a survival interval that was used to build the Kaplan-Meier
survival curve in Figure 3.
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outcome information experienced a progressive course after
the perfusion lung scan interpretation. In only 18 of these 23
cases was the actual interval of survival given. The survival
distribution of these 18 cases ranged from 1 day to 3 months,
with an average of 25.9  30.7 days; 67% of patients (12/18)
died within the first month and 78% within the first 2 months
(14/18) after recognition of the abnormal perfusion pattern.
Although a more thorough statistical analysis could not be
performed from these incomplete values, a simple observa-
tion can be made because that lymphangitic carcinomatosis
perfusion pattern on scintigraphic imaging is highly indica-
tive of a poor prognostic. A Kaplan-Meier survival curve
(Figure 3) was built by taking in consideration the 5 cases
with known follow-up periods and the 18 patients with a re-
ported interval time of death. The initial rapid decline of
cumulative survival rate was followed by a progressive
decline in the cumulative survival rate, with a cumulative
survival rate that decreased below 50% at 21 days after the
recognition of the lymphangitic carcinomatosis perfusion
pattern.
Discussion
In the early 1970s, Pendergrass et al [19] reported a case of
unusual lung perfusion changes, described as peripherally
radiating irregular and linear perfusion defects in addition to
clearly demonstrated fissure hypoperfusion defects. To our
knowledge, this was the first study to link this perfusion pattern
on nuclear medicine imaging with tumour occlusion of
pulmonary vessels and lymphatics. Three cases of lym-
phangitic pulmonary metastases were described in the article
of Sadoff et al [20] in 1976. The term ‘‘lymphangitic carci-
nomatosis’’ in relation to an abnormal perfusion lung scan wasfirst mentioned in an article by Green et al [1], also in 1976.
They described 4 patients with breast cancer and pathology-
proven lymphangitic metastases of the lungs. From these, 2
had normal chest radiographs, and 3 had normal ventilation
lung scans. The perfusion pattern of all the patients, however,
was abnormal, with irregular peripheral defects.
Results of previous studies also proposed widespread
occlusion of pulmonary vessels and lymphatics by tumour
[19] and by pulmonary microemboli [20,21]. After these
initial works, further refinement of the diagnostic interpre-
tation of such perfusion abnormalities have been proposed by
Sostman et al [2] to differentiate lymphangitic carcinoma-
tosis from multiple thromboemboli. They report 2 patients
with a perfusion lung scan that demonstrated ‘‘contour
303Lymphangitic carcinomatosis on V/Q scan / Canadian Association of Radiologists Journal 63 (2012) 294e303mapping’’ of the segments. They proposed that, in carcino-
matosis, the perfusion deficits should be smaller, more
numerous, and outline the bronchopulmonary segments. In
multiple thromboemboli, the defects should be segmental or
subsegmental in distribution.
Crane et al [10] believe the pattern to be primarily the
result of the vascular emboli and peripheral arterial occlu-
sion, and that lymphangitic spread to represent a complica-
tion of tumour microemboli. They propose a combination of
findings to distinguish usual thromboembolic disease from
tumour microemboli: smaller defects, more numerous,
peripherally located, distributed more or less evenly
throughout both lungs.
We believe that our case report is the first to highlight the
importance of recognizing this typical perfusion pattern of
lymphangitic carcinomatosis on perfusion lung scan, even in
patients who are unlikely to have such a diagnosis. The
review of the literature reveals that this pattern was reported
more often in female patients; that the age of the patients at
presentation was distributed in a wide range; and that this
was usually associated with a progressive history of dyspnea,
with normal or mild findings on conventional radiographic
evaluation. Although the quality of this review is hampered
by the heterogeneous information available and its retro-
spective design, a simple observation can be made because
the fragmented perfusion pattern on scintigraphic imaging is
highly indicative of a poor prognosis. This observation
should be confirmed by larger prospective studies.
Conclusion
Whether it is called lymphangitic carcinomatosis, frag-
mented perfusion, or a diffuse tumour microemboli perfusion
pattern, we believe that recognition of such an imaging
configuration by the nuclear medicine physician should be
accompanied by prompt delivery of the report to the treating
physicianwith amention of the poor prognosis associatedwith
this pattern. It also is interesting to note that patients who
survive the initial weeks after such a diagnosis had received
prompt empiric chemotherapy. Without recommending such
an aggressive approach in a routine practice, itmay be useful to
keep in mind that being diligent and raising the suspicion for
a metastatic process may make the difference in the treatment
plan of patients referred to nuclear medicine for otherwise
routine pulmonary thromboembolic disease assessment.
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